Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.

To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

The USD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapy supply chain management software solutions market has been analyzed across the following segments:

Application area

Sample collection and processing

Manufacturing

Logistics

Patient identification and treatment follow-up

Type of software solution

Cell orchestration platform

Enterprise manufacturing system

Inventory management system

Laboratory information management system

Logistics management system

Patient management system

Quality management system

Mode of Deployment

Cloud-based solution

On-premises solution

Scale of Operation

Clinical

Commercial

End user

Biobank

Cell therapy lab / commercial organization

Hospital / medical center

Research institute

Key geographical regions

North America

Europe

Asia Pacific

Rest of the world

The Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking & Tracing Systems, and Other Software), 2019-2030 report features the following companies, which we identified to be key players in this domain:

  • Be The Match BioTherapies®
  • Brooks Life Sciences
  • Clarkston Consulting
  • Cryoport
  • Haemonetics
  • Hypertrust Patient Data Care
  • Lykan Bioscience
  • MAK-SYSTEM
  • MasterControl
  • SAP
  • SAVSU Technologies
  • sedApta Group
  • Stafa Cellular Therapy
  • Title21 Health Solutions
  • TraceLink
  • TrakCel
  • Vineti

Table of Contents

 

1.         Preface

2.         Executive Summary

3.         Introduction

4.         Current Market Landscape

5.         Company Competitiveness Analysis

6.         Cell and Advanced Therapies Supply Chain Management: Company Profiles

7.         Supply Chain Orchestration Platform: Emerging Trends and Key Players

 

8.         Funding and Investment Analysis

 

9.         Partnerships and Collaborations

 

10.       Supply Chain Utilization Use Cases

 

11.       Stakeholder Needs Analysis 

12.       Cost Savings Analysis 

13.       Market Forecast

14.       Executive Insights

15.       Concluding Remarks

16.       Appendix 1: List of Additional Supply Chain Management Software Solutions 

 

17.       Appendix 2: Tabulated Data

18.       Appendix 3: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe